The Journal of Organic Chemistry
Page 22 of 47
1
2
3
4
5
6
7
8
9
[(E)-5- cyclohexyl-5-(p-tolylsulfonylamino)oxy-pent-2-enyl] acetate (1j). General
procedure A was applied to cyclohexanecarboxaldehyde (800 mg, 7.14 mmol). Purification
by flash chromatography on silica gel (PE/Et2O 96/4) yielded 2-(1-cyclohexylbut-3-
1
enoxy)isoindoline-1,3-dione as a yellow oil (1.3 g, 3.1 mmol, 43% for the two steps). H
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
NMR (400 MHz, CDCl3) δ 7.81 (dd, J = 5.4, 3.1 Hz, 2H), 7.73 (dd, J = 5.5, 3.1 Hz, 2H), 5.99
(ddt, J = 17.2, 10.2, 6.9 Hz, 1H), 5.11 (dq, J = 17.2, 1.6 Hz, 1H), 5.04 (dq, J = 10.2 Hz, 1.6
Hz, 1H), 4.13 (q, J = 6.4 Hz, 1H), 2.51 – 2.37 (m, 2H), 1.99 – 1.91 (m, 1H), 1.90 – 1.83 (m,
1H), 1.83 – 1.76 (m, 2H), 1.73 – 1.63 (m, 2H), 1.30 – 1.14 (m, 5H); 13C{1H} NMR (100
MHz, CDCl3) δ 164.3, 134.4, 134.4, 129.1, 123.4, 117.0, 91.0, 39.8, 34.1, 28.2, 28.0, 26.5,
26.2, 26.2; IR (neat, ν/cm-1) : 2925, 2853, 1790, 1729, 1641, 1467, 1449, 1372, 1187, 1122,
1081, 1025; MS (EI, m/z) 164 (9), 137 (14), 136 (26), 104 (29), 96 (8), 95 (100), 94 (9), 93
(8), 90 (16), 83 (16), 82 (10), 81 (85), 79 (17), 77 (13), 76 (30), 69 (20), 67 (50), 55 (79);
HRMS (ESI) Calcd for C18H21NO3 [M+Na]+ : 322.1414, Found : 322.1416. General
procedure B was applied to 2-(1-cyclohexylbut-3-enoxy)isoindoline-1,3-dione (220 mg, 0.74
mmol). Purification by flash chromatography on silica gel (PE/Et2O 90/10) yielded [(E)-5-
cyclohexyl-5-(1,3-dioxoisoindolin-2-yl)oxy-pent-2-enyl] acetate as an oil (192 mg, 0.52
mmol, 70%, E/Z = 75/25). 1H NMR (400 MHz, CDCl3) δ 7.82 (dd, J = 5.5, 3.0 Hz, 2H), 7.74
(dd, J = 5.4, 3.1 Hz, 2H), 6.01 – 5.89 (m, 1H), 5.72 – 5.61 (m, 1H), 4.48 (dd, J = 6.3 Hz, 0.9
Hz, 2H), 4.12 (qapp, J = 5.2 Hz, 1H), 2.56 – 2.37 (m, 2H), 2.03 (s, 3H), 1.99 – 1.91 (m, 1H),
1.90 – 1.84 (m, 1H), 1.83 – 1.74 (m, 2H), 1.74 – 1.63 (m, 2H), 1.32 – 1.11 (m, 5H); 13C{1H}
NMR (100 MHz, CDCl3) δ 170.8, 164.2, 134.4, 131.4, 129.0, 126.4, 123.4, 90.9, 64.8, 40.0,
32.6, 28.4, 27.8, 26.4, 26.2, 26.1, 20.9; IR (neat, ν/cm-1) : 2927, 2853, 1790, 1732, 1467,
1450, 1373, 1232, 1188, 1124, 1082, 1017; MS (EI, m/z) 209 (4), 149 (44), 148 (12), 107
(16), 105 (13), 104 (30), 95 (52), 93 (22), 91 (18), 90 (15), 83 (19), 81 (39), 79 (28), 77 (17),
76 (31), 67 (100), 55 (62), 54 (16), 53 (20); HRMS (ESI) Calcd for C21H25NO5 [M+Na]+ :
394.1625, Found : 394.1628. General procedure C was applied to [(E)-5-cyclohexyl-5-(1,3-
dioxoisoindolin-2-yl)oxy-pent-2-enyl] acetate (190 mg, 0.52 mmol). Purification by flash
chromatography on silica gel (PE/Et2O 70/30) yielded [(E)-5-aminooxy-5-cyclohexyl-pent-2-
enyl] acetate as a colorless oil (76 mg, 0.32 mmol, 61%, E/Z = 80/20). 1H NMR (400 MHz,
CDCl3) δ 5.88 – 5.70 (m, 1H), 5.69 – 5.59 (m, 1H), 4.53 (dapp, J = 6.4 Hz, 2H), 3.36 (qapp, J =
5.7 Hz, 1H), 2.39 – 2.20 (m, 2H), 2.05 (s, 3H), 1.81 – 1.48 (m, 6H), 1.29 – 0.93 (m, 5H);
13C{1H} NMR (100 MHz, CDCl3) δ 170.9, 133.2, 125.7, 87.9, 65.2, 39.8, 32.8, 28.9, 28.6,
26.6, 26.3, 26.2, 21.0; IR (neat, ν/cm-1) : 3319, 2924, 2852, 1736, 1590, 1449, 1365, 1229,
1148, 1024; MS (EI, m/z) 149 (4), 111 (16), 95 (27), 83 (55), 81 (23), 79 (19), 68 (11), 67
ACS Paragon Plus Environment